http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1365749-A4

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6abe8f4287ebbb10ee4e7ddb8eb0e40a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
filingDate 2001-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f0189f5868191dc9954e9c230690691
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16474bfe72291318a561cb4c7ac68b8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4802250b2c689430b75e8f86b16ad92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cb1ac54981f9c847a29fd4a9b61dc1f
publicationDate 2005-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1365749-A4
titleOfInvention PROCESS FOR PREPARING PHARMACEUTICAL COMPOSITIONS FOR USE WITH WEICHGELATINE FORMULATIONS
abstract The invention disclosed herein is a process for increasing the achievable concentration of a pharmaceutically active ingredient relative to fill composition viscosity for dosage units. The process is particularly useful in the preparation of soft gelatin capsules containing ibuprofen, naproxen, indomethacin, and acetaminophen, as the pharmaceutically active ingredient. As a result of the process, lesser quantities of composition ingredients other than the pharmaceutically active ingredient are needed to accomplish the same therapeutically effective dosage, thereby significantly increasing the concentration of the pharmaceutically active ingredient resulting in either a reduction in overall fill volume and dosage unit size or an increase in concentration of pharmaceutically active ingredient per dosage form.
priorityDate 2000-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5360615-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9838987-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400247
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3672
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401799
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21225595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405584
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395293
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID156391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395645

Total number of triples: 37.